Federal contract award
75F40124C00094
DEVELOPING UNIVERSAL CONTROL PEPTIDES FOR T-CELL ASSAYS SUPPORTING IMMUNOGENICITY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | H166 — Quality Control Services: Instruments and Laboratory Equipment |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.3M |
| Current contract value | $1.3M |
| Potential contract value / ceiling | $2.2M |
| Start date | Aug 16, 2024 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Jan 15, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 15, 2026 | P00002 | $241.7K | DEVELOPING UNIVERSAL CONTROL PEPTIDES FOR T-CELL ASSAYS SUPPORTING IMMUNOGENICITY |
| Feb 24, 2025 | P00001 | $0 | MOD P00001 TO CHANGE SCOPE- DEVELOPING UNIVERSAL CONTROL PEPTIDES FOR T-CELL ASSAYS SUPPORTING IMMUNOGENICITY |
| Aug 16, 2024 | 0 | $1.0M | DEVELOPING UNIVERSAL CONTROL PEPTIDES FOR T-CELL ASSAYS SUPPORTING IMMUNOGENICITY |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.